| As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO | Ben Fidler | 11/14/14 | San Francisco |
| Atara Bio Pays the Price for Delayed IPO, Sinks in Debut | Ben Fidler | 10/16/14 | San Francisco |
| Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO | Ben Fidler | 03/25/14 | San Francisco |
| Eleven Prices IPO Below Projected Range, Grabs $50M | Ben Fidler | 02/06/14 | Boston |
| Vaccine Developer Genocea Prices IPO at $12 Per Share | Ben Fidler | 02/05/14 | Boston |
| Vaccine Developer Genocea Files For IPO, Plans to Raise $75M | Ben Fidler | 12/23/13 | Boston |
| Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday | Ben Fidler | 09/19/13 | Boston |
| Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M | Ben Fidler | 08/07/13 | Boston |
